michael b. atkins, md, regarding the long-term follow up of checkmate-004 in metastatic melanoma
Published 5 years ago • 142 plays • Length 2:53
Download video MP4
Download video MP3
Similar videos
-
2:01
michael atkins, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
0:44
michael atkins, md, on follow up investigation of checkmate 025 in renal cell carcinoma patients
-
2:01
dr. atkins on long-term outcomes of the checkmate 204 trial in melanoma
-
1:08
michael b. atkins, md, on the role of imdc classification in treatment decision-making
-
9:44
michael b. atkins, md: new therapies and new questions for metastatic melanoma
-
31:44
melanoma & immunotherapy: ask dr. michael atkins
-
1:26
longterm benefits from nivolumab and ipilimumab combination therapy
-
1:05
dr. hodi on long-term follow-up of nivolumab in patients with melanoma
-
1:37
michael b. atkins, md, comments on clinical trials investigating the use of i-o and tkis in rcc
-
1:01
rana mckay, md, discusses checkmate214 investigating nivolumab ipilimumab in 1st line rcc patients
-
1:24
dr. atkins on adjuvant ipilimumab in melanoma
-
2:35
dr. atkins on long-term survival benefit of nivolumab/ipilimumab in advanced melanoma
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
-
1:48
checkmate 205: 5 year follow-up of nivolumab in hl
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
2:23
dr. michael atkins on immunotherapy or targeted therapy as first treatment for advanced melanoma
Clip.africa.com - Privacy-policy